Compile Data Set for Download or QSAR
maximum 50k data
Found 13 Enz. Inhib. hit(s) with all data for entry = 10047
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510815(N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(piperazin-1-yl...)
Affinity DataIC50:  270nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510819(N-(1-(1H-Indol-3-yl)hexan-2- yl)-5-(4-methylpipera...)
Affinity DataIC50:  370nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510818(N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(4-methylpipera...)
Affinity DataIC50:  390nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510822((S)-N-(1-(1H-Indol-3-yl)hexan- 2-yl)-2-(4-methylpi...)
Affinity DataIC50:  400nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510823((R)-N-(1-(1H-Indol-3-yl)hexan- 2-yl)-2-(4-methylpi...)
Affinity DataIC50:  700nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510820(N-(1-(1H-Indol-3-yl)hexan-2- yl)-5-(4-methylpipera...)
Affinity DataIC50:  770nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510817(N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(2-(4-methylpip...)
Affinity DataIC50:  1.30E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510813(N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(4-methylpipera...)
Affinity DataIC50:  3.33E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510814(N-(2-(1H-Indol-3-yl)ethyl)-2-(4- methylpiperazin-1...)
Affinity DataIC50:  3.55E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510816(N-(2-(1H-Indol-3-yl)ethyl)-2-(2- (4-methylpiperazi...)
Affinity DataIC50:  5.90E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510812(US11078196, Comp. B)
Affinity DataIC50:  6.35E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510821(N-(1-(1H-Indol-3-yl)hexan-2- yl)-2-(4-methylpipera...)
Affinity DataIC50:  8.50E+3nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Ucb Biophama

US Patent
LigandPNGBDBM510811(US11078196, Comp. A)
Affinity DataIC50: >3.00E+4nMAssay Description:The fluorescence polarization assay tests the ability of compounds to inhibit the self-aggregation of α-synuclein peptide fragments. Peptides we...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent